Bioelectronics Corp (BIEL)

[srinsocal]

Once again a lack of understanding the situation

The Boots years gave BIEL its largest revenue years, 2015, 2016, 2017 . It also gave BIEL some of its largest Net Losses because of the costs for a small, one product company to operate in the UK retail space. BIEL exited Boots in 2018 because they were losing money, due to the high costs not because of poor sales, and the NHS approval looked like a way of cutting costs. The NHS proved to be a bust because being on the NHS Drug Tariff does not guarantee that each local NHS bureaucracy, who have had their budgets cut for decades, would authorize paying for all Drug Tariff products. This was an error on BIEL's part for not doing enough research on the NHS system.

KT, with multiple products at Boots, gets volume discounts on their Boots shelf space so they have a much better chance of success there.